Please assess the completion status of the following clinical trial:

Trial Title: Reducing Cannabis Use for Sleep Among Adults Using Medical Cannabis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 21 years or older~* Insomnia Severity Index (ISI) score greater than 10 (indicating mild insomnia),~* Use of cannabis on average three times a week for the past three months,~* Self-reported use of cannabis to manage insomnia at least once a week over the past month,~* Positive drug screen for Tetrahydrocannabinol (THC),~* Consistent access to a telephone, smart phone, laptop, or tablet~Exclusion Criteria:~* Individuals who do not understand English,~* Individuals judged unable to provide informed consent (e.g. intoxication, mental incompetence),~* Diagnosis or high suspicion of a sleep disorder based on validated self-report questionnaires,~* Self-reported cancer,~* Self-reported pregnancy,~* Self-reported rotating or night (3rd) shift work.~* Participants taking medications for sleep will be included if they meet study criteria for insomnia, medications have been stable for at least 8 weeks, and they agree to maintain the same regimen throughout the study.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Cognitive Behavioral Therapy for Insomnia in Cannabis Users (CBTi-CB) (Type: EXPERIMENTAL): None
- Sleep Hygiene Education (SHE) (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).